1. Home
  2. AX vs MRUS Comparison

AX vs MRUS Comparison

Compare AX & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$82.19

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

MRUS

Merus N.V.

HOLD

Current Price

$96.01

Market Cap

5.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
MRUS
Founded
1999
2003
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.1B
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
AX
MRUS
Price
$82.19
$96.01
Analyst Decision
Strong Buy
Buy
Analyst Count
7
17
Target Price
$96.86
$94.94
AVG Volume (30 Days)
266.1K
1.3M
Earning Date
10-30-2025
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.44
N/A
Revenue
$1,202,571,000.00
$56,606,000.00
Revenue This Year
$17.36
$52.81
Revenue Next Year
$10.34
N/A
P/E Ratio
$11.06
N/A
Revenue Growth
6.69
57.54
52 Week Low
$54.46
$33.19
52 Week High
$93.84
$96.28

Technical Indicators

Market Signals
Indicator
AX
MRUS
Relative Strength Index (RSI) 55.13 69.40
Support Level $81.48 $95.74
Resistance Level $83.43 $96.19
Average True Range (ATR) 2.29 0.36
MACD 0.59 -0.36
Stochastic Oscillator 83.01 60.87

Price Performance

Historical Comparison
AX
MRUS

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: